Stock_Titan
Posted - 04/19/24
$LFCR Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report
https://www.stocktitan.net/news/LFCR/lifecore-biomedical-inc-receives-notice-from-nasdaq-regarding-0e4v06dg6ssf.html
Rook1991
Posted - 1 month ago
$LFCR Sleeper blowing this week
tradingtwenty
Posted - 1 month ago
Top 5 oversold stocks that have trended in the past 24 hours: $SIRI 21.99 🔥 $GLPG 25.96 $BRZE 27.74 $NIO 28.14 $LFCR 28.67 Values range from 0 to 100, where 30 or below is oversold and 70 or above overbought. Link: https://tradingtwenty.com/dashboard/trending/past
DonCorleone77
Posted - 1 month ago
$LFCR Lifecore sees 'sufficient liquidity' to achieve plan over next 12 months The Company believes that its capital structure remains in a stable condition following its comprehensive refinancing in May 2023. The Company also believes it has sufficient liquidity to achieve its strategic plan over the next 12 months as of the date hereof. During fiscal year 2024, Lifecore completed the following liquidity and business update matters which are included in the preliminary unaudited historical financial data above and were disclosed as subsequent events in the Company's 2023 Annual Report on Form 10-K. Lifecore successfully entered into an amended and restated supply agreement with one of its customers which provided revised pricing and payment of a $5 million working capital deposit which was received in December 2023. The Company also made significant progress in clearing up former business dealings associated with its since divested Curation Foods segment....
DonCorleone77
Posted - 1 month ago
$LFCR Lifecore sees 2024 revenue $125M-$130M Sees adjusted EBITDA $13.5M-$16.9M. Sees capex $19M-$20M. James G. Hall, President and Chief Executive Officer of Lifecore, commented, "I'm excited to deliver today's business update, which is consistent with the expectations that we laid out last August. Our team has been doing a great job of ramping up our commercial presence in the market over the past two years in advance of our expanded capacity and this has proven to be a timely initiative given recent disruptions within the industry that has created a heightened desire for quality filling capacity. We remain in a strong position with our demonstrated capabilities and focus on quality and are working diligently to bring in new projects and convert existing commercial opportunities within our development portfolio. Lifecore has a lengthy runway of growth ahead with approximately 70 million units of theoretical capacity when our new fillers are installed, tested, and qualified....
Stock_Titan
Posted - 1 month ago
$LFCR Lifecore Biomedical Provides Business Update Outlining Fiscal 2024 Outlook and Year-to-date Progress
https://www.stocktitan.net/news/LFCR/lifecore-biomedical-provides-business-update-outlining-fiscal-2024-dzsnku50up6l.html
Stock_Titan
Posted - 03/26/24
$LFCR Lifecore Biomedical Announces Pending Change of Auditor and Provides Expectation for Business Update
https://www.stocktitan.net/news/LFCR/lifecore-biomedical-announces-pending-change-of-auditor-and-provides-wbx1ne7imsqz.html
_StockTrader
Posted - 03/25/24
Real-Time Stock Data $LFCR
Price: 5.7
Volume: 126503
Market Cap: 173811856
PE Ratio: -40.642857
Powered by: AITX
globallyhomeless
Posted - 03/25/24
$LFCR beautiful move today.
LeroyRunner
Posted - 03/22/24
$LFCR nice breakout
geepeez
Posted - 03/21/24
$LFCR this is getting cheap
ryankay
Posted - 03/21/24
$LFCR rebound is imminent.
Fullratio
Posted - 03/21/24
$LFCR price to sales (P/S) is 34% lower than its 5-year quarterly average of 2.2 and 24% lower than its last 4 quarters average of 1.9: https://fullratio.com/stocks/nasdaq-lfcr/lifecore-biomedical
Game_Day
Posted - 03/20/24
Latest alerts ⭐️ (part 2 of 4)
Options NXT ⭐️ 21%
OLLI ⭐️ 18%
PLTR didnt succeed Stocks $WORX ⭐️ 30%
$ZVAR ⭐️ 4%
$LFCR ⭐️ 4% Signature alerts $AISP 🏆 9% JKS 🏆 currently 30%+
Stocksrunner
Posted - 03/20/24
📉 Today's Top Losers! 📉 $LFCR strategic evaluation ends with disappointment, stock plunges over 35% as uncertainty looms! 💼😞 $AQST takes a dive, plummeting 15% after announcing a hefty $75M offering, investor confidence shaken! 💸😔 $PIXY faces financing challenges, shares drop amid $100M financing terms, casting shadows on future prospects! 💰📉 $SIG sales miss and soft guidance lead to a gloomy outlook, stock tumbles as optimism fades! 💎📉 $FEMY shares falter despite positive trial data, market reacts with skepticism! 👩⚕️📉
ryankay
Posted - 03/20/24
$LFCR wouldn't be surprised if it closes green lol
Zhyg
Posted - 03/20/24
$LFCR -30% on ceo departure news ? thats a joke :D if they will sell company, we will get a nice premium most likely. in with small possition
Bigbossmann
Posted - 03/20/24
$LFCR Looks like shorts may have gotten their teet in a ringer!
globallyhomeless
Posted - 03/20/24
$LFCR in at 4.86 😅
LeroyRunner
Posted - 03/20/24
$LFCR vulture trade. Has had big drops in March and December 2023 and recovered well. RSI on the floor
CheckingMorons
Posted - 03/20/24
$LFCR buyers should step in soon
ryankay
Posted - 03/20/24
$LFCR looking good for an entry here
_www_larval_com_
Posted - 03/20/24
$TGL 12%[80%] $WORX 10%[24%] $BLDE 8%[19%] $LFCR -7%[-24%] $GOEV 6%[1%] most notable movement within the first minutes of trading.
Stock_Titan
Posted - 03/20/24
$LFCR Lifecore Biomedical Concludes Strategic Evaluation Process, Announces Management Succession and Board Changes
https://www.stocktitan.net/news/LFCR/lifecore-biomedical-concludes-strategic-evaluation-process-announces-88u1seoafs1f.html
Stock_Titan
Posted - 03/20/24
$LFCR Lifecore Biomedical Completes Restatements and Files Form 10-K for Fiscal Year 2023
https://www.stocktitan.net/news/LFCR/lifecore-biomedical-completes-restatements-and-files-form-10-k-for-vkbelxd9h15o.html
DH_Explorer
Posted - 03/19/24
$IRIX $EDR $FOUR $QIPT $LFCR Holding all still waiting on buy outs, at + these numbers... IRIX at $6, EDR $32, FOUR at $110, QIPT at $6, LFCR at $120
DailyStocksPicks
Posted - 03/19/24
$AMLX: Significant volatility and a sharp price decline were triggered by the failure of a late-stage ALS trial for its drug Relyvrio, leading to halted promotions and negatively impacting investor sentiment and stock valuation. $LFCR, $ZVRA, $PRLD, $ME For Detailed $AMLX Analysis Watch: https://youtu.be/_2AzeWeByGY
DH_Explorer
Posted - 03/07/24
$IRIX $EDR $FOUR $QIPT $LFCR Companies looking for 'strategic alternative' buyouts...who knows of others???
Stock_Titan
Posted - 02/16/24
$LFCR Lifecore Biomedical, Inc. Announces Receipt of Nasdaq Notice of Delisting and Intention to Appeal
https://www.stocktitan.net/news/LFCR/lifecore-biomedical-inc-announces-receipt-of-nasdaq-notice-of-otu0clhlc2s4.html
